1. Home
  2. LRMR vs LOCO Comparison

LRMR vs LOCO Comparison

Compare LRMR & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • LOCO
  • Stock Information
  • Founded
  • LRMR N/A
  • LOCO 1980
  • Country
  • LRMR United States
  • LOCO United States
  • Employees
  • LRMR N/A
  • LOCO N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • LOCO Restaurants
  • Sector
  • LRMR Health Care
  • LOCO Consumer Discretionary
  • Exchange
  • LRMR Nasdaq
  • LOCO Nasdaq
  • Market Cap
  • LRMR 309.8M
  • LOCO 323.7M
  • IPO Year
  • LRMR N/A
  • LOCO 2014
  • Fundamental
  • Price
  • LRMR $4.10
  • LOCO $9.26
  • Analyst Decision
  • LRMR Strong Buy
  • LOCO Buy
  • Analyst Count
  • LRMR 7
  • LOCO 2
  • Target Price
  • LRMR $16.71
  • LOCO $18.00
  • AVG Volume (30 Days)
  • LRMR 5.0M
  • LOCO 206.7K
  • Earning Date
  • LRMR 11-14-2025
  • LOCO 10-30-2025
  • Dividend Yield
  • LRMR N/A
  • LOCO N/A
  • EPS Growth
  • LRMR N/A
  • LOCO N/A
  • EPS
  • LRMR N/A
  • LOCO 0.85
  • Revenue
  • LRMR N/A
  • LOCO $479,690,000.00
  • Revenue This Year
  • LRMR N/A
  • LOCO $6.34
  • Revenue Next Year
  • LRMR N/A
  • LOCO $1.52
  • P/E Ratio
  • LRMR N/A
  • LOCO $10.96
  • Revenue Growth
  • LRMR N/A
  • LOCO 1.85
  • 52 Week Low
  • LRMR $1.61
  • LOCO $8.29
  • 52 Week High
  • LRMR $9.50
  • LOCO $13.89
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 47.65
  • LOCO 38.25
  • Support Level
  • LRMR $3.88
  • LOCO $9.21
  • Resistance Level
  • LRMR $4.53
  • LOCO $9.81
  • Average True Range (ATR)
  • LRMR 0.42
  • LOCO 0.26
  • MACD
  • LRMR -0.06
  • LOCO 0.00
  • Stochastic Oscillator
  • LRMR 51.10
  • LOCO 22.16

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.

Share on Social Networks: